Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Bell

Showing results (111-120 of 199) with videos related to

Pageof 20
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Enhancing Expression of Functional Human Sodium Iodide Symporter and Somatostatin Receptor in Recombinant Oncolytic Vaccinia Virus for In Vivo Imaging of TumorsJiahu Wang, Rozanne Arulanandam, Richard Wassenaar, et al.
Molecular Therapy. Methods & Clinical Development|August 17, 2018
Use of Precision-Cut Lung Slices as an <i>Ex Vivo</i> Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic TherapyMaría C Rosales Gerpe, Jacob P van Vloten, Lisa A Santry, et al.
The Journal of General Virology|February 14, 2020
Sequencing of serially passaged measles virus affirms its genomic stability and reveals a nonrandom distribution of consensus mutationsMathias Felix Leber, Birgit Hoyler, Stefanie Prien, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunityAnthony T Power, Jiahu Wang, Theresa J Falls, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2022
Perioperative arginine prevents metastases by accelerating natural killer cell recovery after surgeryLeonard Angka, Christiano Tanese de Souza, Katherine E Baxter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamideXue Qing Lun, Ji-Hyun Jang, Nan Tang, et al.
Journal of Virology|November 13, 2009
Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer modelsKilian Guse, Marta Sloniecka, Iulia Diaconu, et al.
Journal of the National Cancer Institute|November 2, 2006
Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomasXueQing Lun, Donna L Senger, Tommy Alain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2013
HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapyByram W Bridle, Lan Chen, Chantal G Lemay, et al.
Cell|December 14, 2011
Suppression of PKR promotes network excitability and enhanced cognition by interferon-γ-mediated disinhibitionPing Jun Zhu, Wei Huang, Djanenkhodja Kalikulov, et al.
Pageof 20

Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Enhancing Expression of Functional Human Sodium Iodide Symporter and Somatostatin Receptor in Recombinant Oncolytic Vaccinia Virus for In Vivo Imaging of TumorsJiahu Wang, Rozanne Arulanandam, Richard Wassenaar, et al.
Molecular Therapy. Methods & Clinical Development|August 17, 2018
Use of Precision-Cut Lung Slices as an <i>Ex Vivo</i> Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic TherapyMaría C Rosales Gerpe, Jacob P van Vloten, Lisa A Santry, et al.
The Journal of General Virology|February 14, 2020
Sequencing of serially passaged measles virus affirms its genomic stability and reveals a nonrandom distribution of consensus mutationsMathias Felix Leber, Birgit Hoyler, Stefanie Prien, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunityAnthony T Power, Jiahu Wang, Theresa J Falls, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2022
Perioperative arginine prevents metastases by accelerating natural killer cell recovery after surgeryLeonard Angka, Christiano Tanese de Souza, Katherine E Baxter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamideXue Qing Lun, Ji-Hyun Jang, Nan Tang, et al.
Journal of Virology|November 13, 2009
Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer modelsKilian Guse, Marta Sloniecka, Iulia Diaconu, et al.
Journal of the National Cancer Institute|November 2, 2006
Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomasXueQing Lun, Donna L Senger, Tommy Alain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2013
HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapyByram W Bridle, Lan Chen, Chantal G Lemay, et al.
Cell|December 14, 2011
Suppression of PKR promotes network excitability and enhanced cognition by interferon-γ-mediated disinhibitionPing Jun Zhu, Wei Huang, Djanenkhodja Kalikulov, et al.
Pageof 20